Safety issues of gene therapy

Cover Page

Cite item

Full Text

Abstract

   By present time safety problems of gene therapy are widely discussed among scientists of all world. In this review results of clinical researches are summarized; explanations concerning side effects of vectors integration are given; factors that can cause genotoxicity are discussed. Approaches which can save or increase clinical efficacy of gene therapy with use as targets hematopoietic stem cells, thus significantly reduced risk of leukemia development and other side effects related to vectors including in genome, are presented.

About the authors

S. E. Ipatov

Federal Research Center of Pediatric Hematology, Oncology and Immunology

Moscow

Russian Federation

S. A. Roumiantsev

Federal Research Center of Pediatric Hematology, Oncology and Immunology

Author for correspondence.
Email: s.roumiantsev@hiidg.ru

Moscow

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2010



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.